Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lucy Lu

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
Frontiers in Cell and Developmental Biology|November 8, 2024
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor responseUnsun Lee, Ludmila Szabova, Victor J Collins, et al.
European Urology Focus|April 7, 2025
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate CancerWilliam B Isaacs, Jun Wei, Marta Gielzak, et al.
Nature Communications|January 26, 2023
DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservationYoungho Kwon, Heike Rösner, Weixing Zhao, et al.
Arxiv|June 9, 2020
CORD-19: The Covid-19 Open Research DatasetLucy Lu Wang, Kyle Lo, Yoganand Chandrasekhar, et al.
IEEE Internet of Things Journal|July 5, 2022
Harnessing the Power of Smart and Connected Health to Tackle COVID-19: IoT, AI, Robotics, and Blockchain for a Better WorldFarshad Firouzi, Bahar Farahani, Mahmoud Daneshmand, et al.
Nature Medicine|April 19, 2005
PI 3-kinase p110beta: a new target for antithrombotic therapyShaun P Jackson, Simone M Schoenwaelder, Isaac Goncalves, et al.
Scientific Reports|September 15, 2022
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodiesXia Cao, Junki Maruyama, Heyue Zhou, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
The Prostate|May 23, 2025
Germline Testing for Prostate Cancer Patients: Evidence-Based Evaluation of Genes Recommended by NCCN GuidelinesJianfeng Xu, Jim Lu, Marta Gielzak, et al.
Frontiers in Cell and Developmental Biology|November 8, 2024
Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor responseUnsun Lee, Ludmila Szabova, Victor J Collins, et al.
European Urology Focus|April 7, 2025
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate CancerWilliam B Isaacs, Jun Wei, Marta Gielzak, et al.
Nature Communications|January 26, 2023
DNA binding and RAD51 engagement by the BRCA2 C-terminus orchestrate DNA repair and replication fork preservationYoungho Kwon, Heike Rösner, Weixing Zhao, et al.
Arxiv|June 9, 2020
CORD-19: The Covid-19 Open Research DatasetLucy Lu Wang, Kyle Lo, Yoganand Chandrasekhar, et al.
IEEE Internet of Things Journal|July 5, 2022
Harnessing the Power of Smart and Connected Health to Tackle COVID-19: IoT, AI, Robotics, and Blockchain for a Better WorldFarshad Firouzi, Bahar Farahani, Mahmoud Daneshmand, et al.
Nature Medicine|April 19, 2005
PI 3-kinase p110beta: a new target for antithrombotic therapyShaun P Jackson, Simone M Schoenwaelder, Isaac Goncalves, et al.
Scientific Reports|September 15, 2022
Unbiased approach to identify and assess efficacy of human SARS-CoV-2 neutralizing antibodiesXia Cao, Junki Maruyama, Heyue Zhou, et al.
Pageof 8